OneSpan Inc. (OSPN) P/E Ratio History
Historical price-to-earnings valuation from 2003 to 2025
Loading P/E history...
Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of March 1, 2026, OneSpan Inc. (OSPN) trades at a price-to-earnings ratio of 5.8x, with a stock price of $11.04 and trailing twelve-month earnings per share of $1.90.
The current P/E is 92% below its 5-year average of 71.6x. Over the past five years, OSPN's P/E has ranged from a low of 6.8x to a high of 525.3x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Technology sector median P/E of 25.2x, OSPN trades at a 77% discount to its sector peers. The sector includes 345 companies with P/E ratios ranging from 0.0x to 199.1x.
Relative to the broader market, OSPN trades at a notable discount to the S&P 500 median P/E of 26.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our OSPN DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
Peer Comparison
P/E metrics vs. Cybersecurity and identity management peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
PANWPalo Alto Networks, Inc. | $105B | 93.1 | - | -56% |
FTNTFortinet, Inc. | $59B | 32.5 | 0.98 | +8% |
CHKPCheck Point Software Technologies Ltd. | $16B | 20.4 | 3.11 | +5% |
GENGen Digital Inc. | $14B | 21.9 | 8.01 | +8% |
QLYSQualys, Inc. | $3B | 19.9 | 0.88Best | +15% |
OKTAOkta, Inc. | $563M | 1208.3 | - | +103% |
OSPNOneSpan Inc. | $412M | 5.8Lowest | - | +30% |
RPDRapid7, Inc. | $395M | 15.6 | - | +116% |
ALLTAllot Ltd. | $251M | 79.1 | - | +153% |
ALARAlarum Technologies Ltd. | $47M | 7.7 | - | +161%Best |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
Historical P/E Data
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q4 | Wed Dec 31 2025 00:00:00 GM | $12.84 | $1.88 | 6.8x | -84% |
| FY2025 Q3 | $15.89 | $1.47 | 10.8x | -75% | |
| FY2025 Q2 | Mon Jun 30 2025 00:00:00 GM | $16.69 | $1.51 | 11.1x | -74% |
| FY2025 Q1 | Mon Mar 31 2025 00:00:00 GM | $15.25 | $1.47 | 10.4x | -76% |
| FY2024 Q4 | $18.54 | $1.45 | 12.8x | -70% | |
| FY2024 Q3 | Mon Sep 30 2024 00:00:00 GM | $16.67 | $0.74 | 22.5x | -47% |
| FY2024 Q2 | Sun Jun 30 2024 00:00:00 GM | $12.82 | $0.43 | 29.7x | -30% |
| FY2020 Q3 | Wed Sep 30 2020 00:00:00 GM | $20.96 | $0.04 | 525.3x | +1132% |
| FY2020 Q2 | $27.93 | $0.38 | 73.2x | +72% | |
| FY2020 Q1 | $18.15 | $0.37 | 48.9x | +15% | |
| FY2019 Q4 | $17.12 | $0.23 | 74.9x | +76% | |
| FY2019 Q3 | Mon Sep 30 2019 00:00:00 GM | $14.50 | $0.20 | 73.0x | +71% |
Average P/E for displayed period: 42.6x
See OSPN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs OSPN Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare OSPN vs NVDA
See how OSPN stacks up against sector leader NVIDIA Corporation.
Start ComparisonFrequently Asked Questions
Is OSPN stock overvalued or undervalued?
OSPN trades at 5.8x P/E, below its 5-year average of 71.6x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does OSPN's valuation compare to peers?
OneSpan Inc. P/E of 5.8x compares to sector median of 25.2x. The discount suggests lower growth expectations or higher risk.
What is OSPN's PEG ratio?
OSPN PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2003-2025.